Finance

Lists
MRCK34:BVMF
Merck BDR
95,05 R$
0,00%
(0,00) 1D
2 հոկ, 17:05:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for MRCK34...
Open
95,05 R$
High
95,05 R$
Low
93,37 R$
Mkt. cap
356,01 մլրդ
Avg. vol.
7,41 հզր
Volume
1,65 հզր
52-wk high
100,98 R$
52-wk low
54,17 R$
Shares outstanding
2,47 մլրդ
No. of employees
74 հզր
Open
95,05 R$
High
95,05 R$
Low
93,37 R$
Mkt. cap
356,01 մլրդ
Avg. vol.
7,41 հզր
Volume
1,65 հզր
52-wk high
100,98 R$
52-wk low
54,17 R$
Shares outstanding
2,47 մլրդ
No. of employees
74 հզր
News stories
From web sources and news partners
BizTimes - Milwaukee Business News
BizTimes - Milwaukee Business News
·
1 օր առաջ
Merck business unit opens R&D facility in Sheboygan Falls
Investor's Business Daily
Investor's Business Daily
·
2 օր առաջ
Moderna Soars On Cancer Vaccine. Is mRNA Ready For Prime Time?
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck BDR
CEORobert M Davis
Employees74 հզր
Founded01 հնվ, 1891 թ.
Headquarters-
Sector-
Websitemerck.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
17,28 մլրդ
16,40 մլրդ
16,29 մլրդ
16,61 մլրդ
Cost of goods sold
3,74 մլրդ
4,30 մլրդ
3,88 մլրդ
4,13 մլրդ
Cost of revenue
3,74 մլրդ
4,30 մլրդ
3,88 մլրդ
4,13 մլրդ
Research and development expenses
4,00 մլրդ
4,00 մլրդ
3,56 մլրդ
9,74 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,48 մլրդ
2,73 մլրդ
2,57 մլրդ
2,78 մլրդ
Operating expense
6,48 մլրդ
6,73 մլրդ
6,12 մլրդ
12,52 մլրդ
Total operating expenses
10,23 մլրդ
11,02 մլրդ
10,00 մլրդ
16,65 մլրդ
Operating income
7,05 մլրդ
5,38 մլրդ
6,29 մլրդ
-40,00 մլն
Other non operating income
-
41,00 մլն
42,00 մլն
59,00 մլն
EBT including unusual items
6,74 մլրդ
3,42 մլրդ
-3,53 մլրդ
-683,00 մլն
EBT excluding unusual items
6,76 մլրդ
4,98 մլրդ
5,85 մլրդ
-508,00 մլն
Income tax expense
958,00 մլն
458,00 մլն
709,00 մլն
654,00 մլն
Effective tax rate
14,20%
13,39%
-20,06%
-95,75%
Other operating expenses
-
-
-
-
Net income
5,78 մլրդ
2,96 մլրդ
-4,24 մլրդ
-1,34 մլրդ
Net profit margin
33,49%
18,07%
-26,03%
-8,04%
Earnings per share
2,58
2,04
-1,28
-0,13
Interest and investment income
96,00 մլն
69,00 մլն
35,00 մլն
35,00 մլն
Interest expense
-327,00 մլն
-411,00 մլն
-479,00 մլն
-525,00 մլն
Net interest expenses
-231,00 մլն
-342,00 մլն
-444,00 մլն
-490,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
8,15 մլրդ
6,79 մլրդ
7,69 մլրդ
1,43 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps